Bjerager, Jakob
Hajari, Javad
Klefter, Oliver Niels
Subhi, Yousif
Schneider, Miklos http://orcid.org/0000-0003-1488-4743
Article History
Received: 27 June 2023
Revised: 29 November 2023
Accepted: 29 December 2023
First Online: 9 January 2024
Declarations
:
: Not applicable. According to Danish law, institutional review board approval is not required for systematic reviews.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Author M. S. has received investigator fees from Allergan, Bayer, Novartis, and Roche and has served as an advisory board member for Novartis and Roche and acted as consultant for AbbVie, not related to this work. Author Y. S. declares to have received speaker fees from Bayer and Roche, not related to this work. Other authors declare that no potential conflicts of interests exist in relation to this work.